These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4045400)

  • 1. Cervical dilatation in the nonpregnant patient with vaginal 16-dimethyl prostaglandin E2.
    Nuss RC; Baird T; Benrubi G; Thompson RJ
    J Fla Med Assoc; 1985 Jun; 72(6):426-7. PubMed ID: 4045400
    [No Abstract]   [Full Text] [Related]  

  • 2. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
    Lauersen NH; Graves ZR
    J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].
    Friedli A; De Grandi P
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.
    Hald F; Kristoffersen SE; Gregersen E
    Acta Obstet Gynecol Scand; 1988; 67(3):219-22. PubMed ID: 3051874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
    Sidhu MS; Kent DR
    Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of 16,16'-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal suppository for cervical dilatation in premenopausal and postmenopausal women.
    Rabe T; Willinger G; Kiesel L; Runnebaum B; Kubili F; Mösche R; Nobakht N
    Adv Contracept; 1985 Mar; 1(1):91-102. PubMed ID: 3916041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative cervix dilatation in 1st trimester pregnancy interruption using 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2. A randomized double-blind study].
    Brügger D; Dreher E
    Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):567-9. PubMed ID: 4043711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
    Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
    Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
    Shapiro AG; Lasseter K; Cobiella A; Domenzain M
    Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
    Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
    Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal administration of gemeprost for preoperative cervical dilatation in non pregnant patients.
    Martinelli P; Locci M; Guerritore T; Arpaia F; Di Meglio G; Giannitelli A; Latorre PC; Montemagno U
    Clin Exp Obstet Gynecol; 1989; 16(2-3):61-4. PubMed ID: 2758667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of meteneprost potassium (a PGE2 analogue) for cervical dilation and side effects in nonpregnant women.
    Eder SE; Chatterjee M; Salvio C
    Prostaglandins; 1986 Jul; 32(1):19-23. PubMed ID: 3763945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative cervical dilatation by vaginal pessaries containing prostaglandin E1 analogue.
    Chen JK; Elder MG
    Obstet Gynecol; 1983 Sep; 62(3):339-42. PubMed ID: 6348613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative dilatation of the first-trimester cervix: a comparison between Lamicel and 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester pessaries.
    Welch CC; Macpherson M; Johnson IR; Nicolaides K; Filshie GM
    Am J Obstet Gynecol; 1984 Jun; 149(4):400-2. PubMed ID: 6731518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endocervical administration of prostaglandin E2 on cervical dilatation and connective tissue biosynthesis in the first trimester of pregnancy.
    Norström A
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():461-4. PubMed ID: 6221632
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaginal misoprostol for cervical priming before dilatation and curettage in postmenopausal women: a randomized controlled trial.
    Bunnasathiansri S; Herabutya Y; O-Prasertsawat P
    J Obstet Gynaecol Res; 2004 Jun; 30(3):221-5. PubMed ID: 15210047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. IV. Possible modalities of its use in gynecology].
    Stoppelli I; Piras G; Dessole S
    Minerva Ginecol; 1983 Dec; 35(12):833-4. PubMed ID: 6672685
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of 16, 16-dimethyl-prostaglandin E2 in the human female.
    Steffenrud S
    Biochem Med; 1980 Dec; 24(3):274-92. PubMed ID: 7283984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.